KY Biotechnology & Medical Research

Connect Biopharma Holdings Ltd (CNTB)

Connect Biopharma Holdings Ltd has recorded no insider trading activity within the past three months. The most recent transactions occurred on May 29, 2026, involving share purchases by James Huang. Prior historical filings indicate various proposed sales by major stockholders throughout 2025 and 2023.
Ticker: CNTB Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.4
Huang James Non-Executive Director
Transaction date
Purchase
Price
389.07
Quantity 76,040 -38.7%
Value US$216,038
2.4
Huang James Non-Executive Director
Transaction date
Purchase
Price
86.70
Quantity 93,359 +38.2%
Value US$4,553,451
2.2
Panacea Innovation Limited 10% Owner Large shareholder
Transaction date
Proposed sale
Price
448.92
Quantity 78,275
Value US$1,820,248
Wei Zheng 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
3.19
Quantity 650,000
Value US$2,073,500
BioFortune Inc 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.49
Quantity 500,000
Value US$1,245,000
Wei Zheng 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.53
Quantity 200,000
Value US$305,940
Wei Zheng 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.81
Quantity 39,775
Value US$32,218
RA Capital Nexus Fund, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.94
Quantity 295,650
Value US$279,034
RA Capital Healthcare Fund LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.94
Quantity 1,765,788
Value US$1,666,551
RA Capital Nexus Fund, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.90
Quantity 36,959
Value US$33,263
RA Capital Healthcare Fund LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
0.90
Quantity 220,738
Value US$198,664
RA Capital Nexus Fund, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.29
Quantity 151,778
Value US$195,793
RA Capital Healthcare Fund LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
1.29
Quantity 906,504
Value US$1,169,390
RA Capital Nexus Fund, L.P. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.06
Quantity 78,983
Value US$162,704
RA Capital Healthcare Fund LP 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
2.06
Quantity 471,732
Value US$971,767
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-05-29 B Purchase
2.4
Huang James
Non-Executive Director
76,040 -38.7%
389.07
US$216,038 		76,040 -38.7% 389.07 US$216,038
2026-04-01 2026-03-31 B Purchase
2.4
Huang James
Non-Executive Director
93,359 +38.2%
86.70
US$4,553,451 		93,359 +38.2% 86.70 US$4,553,451
2025-11-24 2025-11-24 PrS Proposed sale
2.2
Panacea Innovation Limited

10% Owner

Large shareholder
78,275
448.92
US$1,820,248 		78,275 448.92 US$1,820,248
2025-11-21 2025-11-21 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
650,000
3.19
US$2,073,500 		650,000 3.19 US$2,073,500
2025-11-18 2025-11-18 PrS Proposed sale
BioFortune Inc

10% Stockholder

Large shareholder
500,000
2.49
US$1,245,000 		500,000 2.49 US$1,245,000
2025-10-01 2025-10-01 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
200,000
1.53
US$305,940 		200,000 1.53 US$305,940
2025-06-11 2025-06-11 PrS Proposed sale
Wei Zheng

10% Stockholder

Large shareholder
39,775
0.81
US$32,218 		39,775 0.81 US$32,218
2023-12-18 2023-12-18 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
295,650
0.94
US$279,034 		295,650 0.94 US$279,034
2023-12-18 2023-12-18 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
1,765,788
0.94
US$1,666,551 		1,765,788 0.94 US$1,666,551
2023-12-12 2023-12-12 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
36,959
0.90
US$33,263 		36,959 0.90 US$33,263
2023-12-12 2023-12-12 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
220,738
0.90
US$198,664 		220,738 0.90 US$198,664
2023-11-27 2023-11-27 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
151,778
1.29
US$195,793 		151,778 1.29 US$195,793
2023-11-27 2023-11-27 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
906,504
1.29
US$1,169,390 		906,504 1.29 US$1,169,390
2023-11-21 2023-11-21 PrS Proposed sale
RA Capital Nexus Fund, L.P.

10% Stockholder

Large shareholder
78,983
2.06
US$162,704 		78,983 2.06 US$162,704
2023-11-21 2023-11-21 PrS Proposed sale
RA Capital Healthcare Fund LP

10% Stockholder

Large shareholder
471,732
2.06
US$971,767 		471,732 2.06 US$971,767
Explore more

More insider trading research around Connect Biopharma Holdings Ltd

More insider trades in KY
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity